檢索結果 - Christof Scheid
- Showing 1 - 20 results of 42
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality 由 Kirsten Alexandra Eberhardt, Verena Jung, Elena Knops, Eva Heger, Maike Wirtz, Gertrud Steger, Rolf Kaiser, Patrick Affeldt, Udo Holtick, Florian Klein, Christof Scheid, Veronica Di Cristanziano
出版 2023Artigo -
7
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis 由 Lena M. Biehl, Jörg Janne Vehreschild, Blasius Liss, Bernd Franke, Birgid Markiefka, Thorsten Persigehl, Vanessa Bücker, Hilmar Wisplinghoff, Christof Scheid, Oliver A. Cornely, Maria J. G. T. Vehreschild
出版 2016Artigo -
8
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD 由 Madan Jagasia, Christof Scheid, Gèrard Socié, Francis Ayuk, Johanna Tischer, Michèle L. Donato, Árpád Bátai, Heidi Chen, Sheau‐Chiann Chen, Thomas K. Chin, Henri Boodée, Ghaith Mitri, Hildegard Greinix
出版 2019Artigo -
9
<scp>OCTET</scp>‐<scp>CY</scp>: a phase <scp>II</scp> study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic p... 由 Udo Holtick, Jens‐Markus Chemnitz, Alexander Shimabukuro‐Vornhagen, Sebastian Theurich, Geothy Chakupurakal, Anke Krause, Anne Fiedler, Leo Luznik, Martin Hellmich, Dominik Wolf, Michael Hallek, Michael von Bergwelt‐Baildon, Christof Scheid
出版 2015Artigo -
10
Characteristics of Infections after BCMA-directed CAR-T cells therapy for Multiple Myeloma - a real-world analysis 由 Tim Richardson, Daniel Schuette, Guido Kobbe, Ben‐Niklas Baermann, Tobias A.W. Holderried, Friederike Schmitz, Martina Crysandt, Michael Hallek, Christof Scheid, Udo Holtick, Oliver A. Cornely, Jannik Stemler, Sibylle C. Mellinghoff
出版 2025Artigo -
11
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial 由 Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Joerg Thomas Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony D. Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, Peter Dreger
出版 2017Carta -
12
Single <i>versus</i> tandem high‐dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long‐term results from the phase <scp>III GMMG</scp>‐<sc... 由 K. Elias, Axel Benner, Uta Bertsch, Peter Brossart, Annette Hänel, Volker Kunzmann, Ralph Naumann, Kai Neben, Gerlinde Egerer, Anthony D. Ho, Jens Hillengaß, Marc S. Raab, Andreas Neubauer, Astrid Peyn, Yon‐Dschun Ko, Norma Peter, Christof Scheid, Hartmut Goldschmidt
出版 2016Artigo -
13
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma 由 K. Elias, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor Wolfgang Blau, Mathias Hänel, Hans Salwender, Axel Benner, Marc S. Raab, Hartmut Goldschmidt, Niels Weinhold
出版 2023Artigo -
14
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial 由 Peter Dreger, Andrea Schnaiter, Thorsten Zenz, Sebastian Böttcher, Marianna Rossi, Peter Paschka, Andreas Bühler, Sascha Dietrich, Raymonde Busch, Matthias Ritgen, Donald Bunjes, Matthias Zeis, Michael Stadler, Lutz Uharek, Christof Scheid, Ute Hegenbart, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, Stephan Stilgenbauer
出版 2013Artigo -
15
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CL... 由 Peter Dreger, Hartmut Döhner, Matthias Ritgen, Sebastian Böttcher, Raymonde Busch, Sascha Dietrich, Donald Bunjes, Sandra Cohen, Jörg Schubert, Ute Hegenbart, Dietrich W. Beelen, Matthias Zeis, Michael Stadler, Justin Hasenkamp, Lutz Uharek, Christof Scheid, Andreas Humpe, Thorsten Zenz, Dirk Winkler, Michael Hallek, Michael Kneba, Norbert Schmitz, Stephan Stilgenbauer
出版 2010Artigo -
16
Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change 由 Maximilian Christopeit, Oliver Kuß, Jürgen Finke, Ulrike Bacher, Dietrich W. Beelen, Martin Bornhäuser, Rainer Schwerdtfeger, Wolfgang Bethge, Nadežda Basara, Martin Gramatzki, Johanna Tischer, Hans‐Jochem Kolb, Lutz Uharek, Ralf G. Meyer, Donald Bunjes, Christof Scheid, Hans Martin, Dietger Niederwieser, Nicolaus Kröger, Hartmut Bertz, Hubert Schrezenmeier, Christoph Schmid
出版 2013Artigo -
17
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Stu... 由 Carmen Martı́nez, Jorge Gayoso, Carmen Canals, Hervé Finel, Karl S. Peggs, Alida Dominietto, Luca Castagna, Boris V. Afanasyev, Stephen Robinson, Didier Blaise, Paolo Corradini, Maija Itälä‐Remes, Arancha Bermúdez, Édouard Forcade, Domenico Russo, Michael Potter, Grant McQuaker, Ibrahim Yakoub‐Agha, Christof Scheid, Adrian Bloor, Silvia Montoto, Peter Dreger, Anna Sureda
出版 2017Artigo -
18
A phase 2 clinical trial of combined BRAF/MEK inhibition for <i>BRAF</i>V600E-mutated multiple myeloma 由 Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M. Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole A. Becker, Thomas Moehler, Ivana von Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann‐Grill, K. Martin Kortüm, Carsten Müller‐Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja Weisel, Marc S. Raab
出版 2023Artigo -
19
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC) 由 Christian Niederwieser, Simona Iacobelli, Georg‐Nikolaus Franke, Linda Köster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Müller, Matthias Stelljes, Еlena V. Morozova, Jakob Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Bethge, Xavier Poiré, Guido Kobbe, Donal P. McLornan, Marie Robin, Nicolaus Kröger
出版 2024Artigo -
20
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma 由 E. K., Uta Bertsch, Jan Dürig, Christina Kunz, Mathias Haenel, Igor Wolfgang Blau, Markus Munder, A. Jauch, B. Schurich, Thomas Hielscher, Maximilian Merz, Barbara Huegle-Doerr, Anja Seckinger, Dirk Hose, Jens Hillengaß, Marc‐Steffen Raab, Kai Neben, H-W Lindemann, Matthias Zeis, Christian Gerecke, Ingo Schmidt‐Wolf, Katja Weisel, Christof Scheid, Hans Salwender, Hartmut Goldschmidt
出版 2015Artigo
相關主題
Internal medicine
Medicine
Oncology
Transplantation
Surgery
Gastroenterology
Multiple myeloma
Chemotherapy
Immunology
Hematopoietic stem cell transplantation
Biology
Physics
Cyclophosphamide
Randomized controlled trial
Clinical endpoint
Genetics
Adverse effect
Bone marrow
Confidence interval
Clinical trial
Hazard ratio
Incidence (geometry)
Leukemia
Melphalan
Optics
Progression-free survival
Stem cell
Antibody
Astrobiology
Bortezomib